NIH-funded research R21 grant

Improving T-cell access to difficult-to-treat tumors using advanced imaging and machine learning

Official title: Defining therapeutic strategies for boosting T-cell infiltration into cold tumors with spatial proteomics and machine learning

Funded at California Institute of Technology · NIH-10743501 · Data updated 2026-11-12

This study is looking at ways to make cancer treatments work better for patients with cold tumors, which are tough because they don't have many immune cells fighting the cancer; by using advanced technology to understand the tumor environment, the researchers hope to find new ways to help the immune system do its job.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionCalifornia Institute of Technology
NIH-funded
Lab location1 site (Pasadena, United States)
Project startSeptember 5, 2023
Project endAugust 31, 2025
Funding year2023
Award (this year)$423,078
NIH project number1R21CA284221-01
Project IDNIH-10743501 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with cold tumors, such as certain types of breast, liver, prostate, or colon cancers, who have not responded to standard immunotherapy treatments.

Less likely to help

Patients with hot tumors, where T-cell infiltration is already effective, may not benefit from this specific research.

What this research studies

This research focuses on enhancing the effectiveness of immunotherapies for patients with cold tumors, which are characterized by low T-cell infiltration due to suppressive environments created by cancer cells. By utilizing advanced spatial proteomic techniques, the study aims to analyze the tumor microenvironment at a molecular level to identify factors that inhibit T-cell function. The project employs machine learning algorithms to process large datasets, ultimately seeking to develop targeted therapeutic strategies that can be tested in clinical settings to improve T-cell access and activity in these challenging tumors.

Why it matters

Potential benefit: If successful, this research could lead to new treatment options that enhance the effectiveness of immunotherapies for patients with cold tumors, potentially improving outcomes for those with difficult-to-treat cancers.

How similar studies have gone: While the approach of using spatial proteomics and machine learning is innovative, similar strategies in other contexts have shown promise in enhancing immunotherapy effectiveness, indicating potential for success.

Where this research is happening

  • California Institute of Technology
    Pasadena, United States
    Active

Researchers

  • Principal investigator: Thomson, Matthew W. — California Institute of Technology
  • Study coordinator: Thomson, Matthew W.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.